Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.


The search for biomarkers in the management of lung cancer involves the use of multiple platforms to examine changes in gene, protein, and microRNA expression. Multiple studies have been published in an attempt to describe early detection, diagnostic, prognostic, and predictive biomarkers using chiefly tissues and blood elements. Studies are characterized by a lack of commonality of specific biomarkers, and a lack of validated, clinically useful markers. The future of biomarker discovery as a means of tailoring therapy for patients with lung cancer will involve next-generation sequencing along with collaborative efforts to integrate and validate candidate markers.

  • Beer DG
  • Joseph S
  • Massion P
  • Pass HI
PubMed ID
Appears In
Thorac Surg Clin, 2013, 23 (2)